Acute vincristine pretreatment protects adult mouse cardiac myocytes from oxidative stress

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 3, 2007, Pages 327-336

  Chatterjee, Kanu ^a,c   Zhang, Jianqing ^b   Honbo, Norman ^b   Simonis, Uschi ^d   Shaw, Robin ^a   Karliner, Joel S ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

Cardiac myocytes; Cardioprotection; Cell culture; Hydrogen peroxide; Hypoxia; Oxidative stress; Signal transduction; Vincristine

Indexed keywords

CYTOCHROME C; DOXORUBICIN; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PACLITAXEL; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; TRYPAN BLUE; VINCRISTINE;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART PROTECTION; HYPOXIA; INCUBATION TIME; MICROSCOPY; MICROTUBULE; MOUSE; MUSCLE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; CARDIOTONIC AGENTS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART VENTRICLES; HYDROGEN PEROXIDE; MALE; MICE; MICE, INBRED C57BL; MICROTUBULES; MYOCYTES, CARDIAC; OXIDANTS; OXIDATIVE STRESS; TIME FACTORS; VINCRISTINE;

EID: 34548133146     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.06.005     Document Type: Article

References (33)

1. Blasko G., and Cordel G.A. In: Brossi A., and Suffness M. (Eds). The Alkaloids: Antitumor Bisondole Alkaloids from Catharanhus roseus (L) vol. 37, (Chapter 1) (1990), Academic Press, San Diego 1-76
2. Jordon M.A. Anti-cancer agents. Curr. Med. Chem. 2 (2002) 1-17
3. Mollinedo F., and Gajate C. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8 (2003) 413-450
4. Chu E., and Sartorelly A.C. Cancer chemotherapy. In: Katzung B.G. (Ed). Basic and Clinical Pharmacology. 9th ed. (2004), Lange Medical Books/McGraw-Hill, New York 898-930 chapter 55
5. Skobel E., and Kammermeier H. Relation between enzyme release and irreversible cell injury of the heart under the influence of cytoskeleton modulating agents. Biochim. Biophys. Acta 1362 (1997) 28-134
6. Zhou Y.-Y., Wang S.-Q., Zhu W., Chruscinski A., Kobilka B.K., Wang S., et al. Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am. J. Physiol.: Heart Circ. Physiol. 279 (2000) H429-H436
7. Saijo N. A spectrophotometric quantitation of cytotoxic action of antiserum and complement by trypan blue. Immunology 24 (1973) 683-690
8. Kacimi R., Chentoufi J., Honbo N., Long C.S., and Karliner J.S. Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: role of the p38 stress-activated kinase signaling cascade, and relation to cytoprotection. Cardiovasc. Res. 46 (2002) 139-150
9. Karliner J.S., Honbo N., Summers K., Gray M.O., and Goetzl E.J. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J. Mol. Cell. Cardiol. 33 (2001) 1713-1717
10. Armstrong S.C., and Ganote C.E. Effects of 2,3-butanedione monoxime (BDM) on contracture and injury of isolated rat myocytes following metabolic inhibition and ischemia. J. Mol. Cell. Cardiol. 23 (1991) 1001-1014
11. Gray M.O., Karliner J.S., and Mochly-Rosen D. A selective epsilon protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J. Biol. Chem. 272 (1997) 30945-30951
12. Jacobson M.D., Weil M., and Raff M.C. Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell Biol. 133 (1996) 1041-1051
13. Weil M., Jacobson M.D., Coles H.S., Davies T.J., Gardner R.L., Raff K.D., et al. Constitutive expression of the machinery for programmed cell death. J. Cell Biol. 133 (1996) 1053-1059
14. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., et al. Glycogen synthase kinase-3 beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 113 (2004) 1535-1549
15. Zhou Y.Y., Wang S.Q., Zhu W.Z., Chruscinski A., Kobilka B.K., and Ziman B. Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am. J. Physiol.: Heart Circ. Physiol. 279 (2000) H429-H436
16. Hilal-Dandan R., Kanter J.R., and Brunton L.L. Characterization of G protein signaling in ventricular myocytes from the adult mouse heart: differences from the rat. J. Mol. Cell. Cardiol. 32 (2000) 1211-1221
17. 2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J. Clin. Invest. 100 (1997) 380-389
18. Sollott S.J., Ziman B.D., Warshaw D.M., Spurgeon H.A., and Lakatta E.G. Actomyosin interaction modulates resting length of unstimulated cardiac ventricular cells. Am. J. Physiol.: Heart Circ. Physiol. 40H (1996) H896-H905
19. Wilson L., Panda D., and Jordan M.A. Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators. Cell Struct. Funct. 24 (1999) 329-335
20. Nogales E., Whittaker M., Milligan R.A., and Downing K.H. High resolution model of the microtubule. Cell 96 (1999) 79-88
21. Schlaifer D., Cooper M.R., Attal M., Sartor O., Terpel J.B., Laurent G., et al. Myeloperoxidase: an enzyme involved in intrinsic vincristine resistance in human myeloblastic leukemia. Blood 81 (1993) 482-489
22. Marte B.M., and Downward J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22 (1997) 355-358
23. Uchiyama T., Engleman R.M., Maulik N., and Das D.K. Role of AKT signaling in mitochondrial survival pathways triggered by hypoxic preconditioning. Circulation 109 (2004) 3042-3049
24. Borutaite V., Jekabsone A., Morkuniene R., and Brown G.C. Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release, and apoptosis induced by heart ischemia. J. Mol. Cell. Cardiol. 35 (2003) 357-366
25. Lesnefsky E.J., Chen Q., Mohaddas S., Hassan M.O., Tandler B., and Hoppel C.L. Blockade of electron transport during ischemia protects cardiac mitochondria. J. Biol. Chem. 279 (2004) 47961-47967
26. 2 and cumene hydroperoxide treatment on heart mitochondria. J. Bioenerg. Biomembr. 38 (2006) 327-333
27. Wang T.-H., Wang H.S., Ichijo H., Giannakakou P., Foster J.S., and Fojo T. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem. 273 (1998) 4928-4936
28. Srivastava R.K., Srivstava A.R., Korsmeyer S.J., Nesterova M., and Cho-Chung Y.S. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 18 (1998) 3509-3517
29. Wang L.G., Liu X.M., Kreis W., and Budman D.R. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother. Pharmacol. 44 (1999) 355-361
30. Stone A.A., and Chambers T.C. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK and p38) signaling pathways in human KB-3 carcinoma cells. Exp. Cell Res. 254 (2000) 110-119
31. Huang Y., Fang Y., Wu J., Dziadyk J.M., Zhu X., et al. Regulation of vinca alkaloid-induced apoptosis by NFκB/IκB pathway in human tumor cells. Mol. Cancer Ther. 3 (2004) 271-277
32. Kang W., Lee I., Ko U., and Park C. Differential effects of rhoA signaling on anticancer agent-induced cell death. Oncol. Rep. 13 (2005) 299-304
33. VanderWeele D.J., and Rudin C.M. Mammalian target of rapamycin promotes vincristine resistance through multiple mechanisms independent of maintained glycolytic rate. Mol. Cancer Res. 3 (2005) 635-644